Healthcare > Diagnostics & Lab Services
•31 stocks
•
Total Market Cap: Loading...
Price Performance Heatmap
5Y Price (Market Cap Weighted)
All Stocks (31)
| Company | Market Cap | Price |
|---|---|---|
|
LH
Labcorp Holdings Inc.
Labcorp operates a network of clinical laboratories delivering diagnostic testing services.
|
$22.51B |
$270.99
+0.78%
|
|
DGX
Quest Diagnostics Incorporated
Quest Diagnostics operates a nationwide network of clinical labs, i.e., clinical lab chains delivering diagnostic testing services.
|
$21.19B |
$189.49
-0.40%
|
|
EXAS
Exact Sciences Corporation
The company operates clinical laboratory testing capabilities as part of delivering its diagnostic products and services.
|
$19.39B |
$102.46
+0.12%
|
|
GH
Guardant Health, Inc.
Clinical Lab Chains: Guardant operates CLIA-certified lab operations to process tests.
|
$13.98B |
$112.17
+0.17%
|
|
TEM
Tempus AI, Inc.
Clinical Lab Chains – Tempus operates clinical laboratories delivering sequencing-based diagnostics, expanded by the Ambry Genetics acquisition.
|
$12.22B |
$70.31
+2.02%
|
|
DVA
DaVita Inc.
DaVita operates clinical laboratory testing facilities and diagnostic services as part of its dialysis and kidney care offerings.
|
$7.49B |
$104.74
-1.04%
|
|
HIMS
Hims & Hers Health, Inc.
Clinical laboratory chains / lab testing services through Trybe Labs.
|
$7.09B |
$31.43
+0.62%
|
|
SHC
Sotera Health Company
Nelson Labs operates clinical lab testing facilities, i.e., lab chains, as part of its testing services.
|
$5.45B |
$19.18
-0.88%
|
|
GRAL
GRAIL, Inc.
Company operates clinical laboratory testing capabilities to run Galleri and related studies.
|
$3.49B |
$96.69
-0.77%
|
|
WGS
GeneDx Holdings Corp.
Clinical lab chains providing genetic testing services.
|
$3.10B |
$107.89
-1.27%
|
|
CON
Concentra Group Holdings Parent, Inc.
The business provides diagnostic testing via its clinics, aligning with laboratory testing and diagnostic service capabilities.
|
$2.76B |
$21.55
-0.14%
|
|
ADPT
Adaptive Biotechnologies Corporation
Partnership activity with NeoGenomics reflects ADPT's role in clinical lab testing services / lab chains.
|
$2.67B |
$17.51
-1.52%
|
|
QDEL
QuidelOrtho Corporation
Clinical lab chains/diagnostic service networks align with QuidelOrtho’s lab-based business model and scale.
|
$2.25B |
$33.19
-6.19%
|
|
NEOG
Neogen Corporation
Genomics services and diagnostic testing capabilities may be organized or delivered through clinical lab networks, aligning with Clinical Lab Chains.
|
$2.01B |
$9.24
-2.27%
|
|
AZTA
Azenta, Inc.
Genewiz operates as a clinical lab network, aligning with Clinical Lab Chains.
|
$1.83B |
$40.01
+0.25%
|
|
NEO
NeoGenomics, Inc.
NeoGenomics operates a network of cancer-focused testing laboratories, i.e., clinical lab chains.
|
$1.65B |
$12.78
-0.43%
|
|
CDNA
CareDx, Inc
Operates as Clinical Lab Chains or core laboratory testing facilities providing diagnostic services.
|
$1.07B |
$20.00
-2.77%
|
|
FLGT
Fulgent Genetics, Inc.
Company operates clinical lab chains providing diagnostic testing.
|
$859.50M |
$28.10
-1.92%
|
|
MYGN
Myriad Genetics, Inc.
Clinical lab chains—multiplicity of testing locations and labs enabling national testing services.
|
$550.82M |
$5.92
-1.99%
|
|
SOPH
SOPHiA GENETICS S.A.
Clinical Lab Chains: target customers include clinical laboratories and networks leveraging the platform.
|
$368.31M |
$5.46
+5.81%
|
|
BNR
Burning Rock Biotech Limited
Operates clinical laboratory testing facilities (central lab/in-hospital model).
|
$344.69M |
$32.26
-3.18%
|
|
XGN
Exagen Inc.
Exagen’s core diagnostic testing capability places it within clinical lab chains as a diagnostic testing provider.
|
$103.20M |
$4.69
-2.90%
|
|
AKYA
Akoya Biosciences, Inc.
Clinical lab chains alignment with the company’s lab services and clinical testing offerings.
|
$64.26M |
$1.29
|
|
CDIX
Cardiff Lexington Corporation
Nova Ortho & Spine provides diagnostic and related assessment services, aligning with Diagnostics & Lab Services in Healthcare.
|
$58.18M |
$4.32
|
|
PRPO
Precipio, Inc.
Pathology/clinical lab services and diagnostic testing operations.
|
$38.06M |
$23.49
-2.13%
|
|
TRIB
Trinity Biotech plc
Operates Immco NYSDOH-certified clinical laboratory for diagnostic testing.
|
$12.36M |
$0.69
-3.17%
|
|
BNGO
Bionano Genomics, Inc.
BNGO has historically operated Clinical Lab Chains as part of its diagnostic services portfolio.
|
$7.35M |
$1.55
-1.27%
|
|
APM
Aptorum Group Limited
Diagnostics platform potentially operating as a network of clinical labs; reflects lab-based service delivery.
|
$5.78M |
$1.04
-0.95%
|
|
DFCO
Dalrada Financial Corporation
Boost Diagnostics provides diagnostic testing capabilities, consistent with clinical lab chains.
|
$5.38M |
$0.03
|
|
POAI
Predictive Oncology Inc.
CLIA-certified wet-lab operations and clinical-lab-style testing/validation services.
|
$4.32M |
$5.94
-0.17%
|
|
BIAF
bioAffinity Technologies, Inc.
The company operates clinical laboratory testing facilities as part of CyPath Lung, aligning with 'Clinical Lab Chains'.
|
$1.30M |
$1.35
-4.93%
|
Loading company comparison...
Loading industry trends...
Loading research report...
